Resources from the same session
LBA55 - Trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutant metastatic non-small cell lung cancer (NSCLC): Interim results from the phase 2 DESTINY-Lung02 trial
Presenter: Koichi Goto
Session: Mini Oral session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
LBA56 - MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial
Presenter: Myung-Ju Ahn
Session: Mini Oral session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA55 and LBA56
Presenter: Laura Mezquita
Session: Mini Oral session: NSCLC, metastatic
Resources:
Slides
Webcast
LBA57 - Sintilimab plus anlotinib versus platinum-based chemotherapy as first-line therapy in metastatic NSCLC (SUNRISE): An open label, multi-center, randomized, phase II study
Presenter: Baohui Han
Session: Mini Oral session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
LBA58 - Sintilimab with or without IBI305 plus chemotherapy in patients with EGFR mutated non-squamous non-small cell lung cancer (EGFRm nsqNSCLC) who progressed on EGFR tyrosine-kinase inhibitors (TKIs) therapy: Second interim analysis of phase III ORIENT-31 study
Presenter: Shun Lu
Session: Mini Oral session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA57 and LBA58
Presenter: Tony S.K. Mok
Session: Mini Oral session: NSCLC, metastatic
Resources:
Slides
Webcast
LBA59 - Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)
Presenter: Melissa Johnson
Session: Mini Oral session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
973MO - KEYNOTE-189 5-year update: First-line pembrolizumab (pembro) + pemetrexed (pem) and platinum vs placebo (pbo) + pem and platinum for metastatic nonsquamous NSCLC
Presenter: Marina Garassino
Session: Mini Oral session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
974MO - 5-year update from KEYNOTE-407: Pembrolizumab plus chemotherapy in squamous non-small cell lung cancer (NSCLC)
Presenter: Silvia Novello
Session: Mini Oral session: NSCLC, metastatic
Resources:
Abstract
Slides
Webcast